Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Vision Holdings (EYE) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for National Vision Holdings (EYE) over the last 10 years, with Q1 2025 value amounting to $1.0 million.

  • National Vision Holdings' Asset Writedowns and Impairment fell 2303.7% to $1.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year increase of 2291.2%. This contributed to the annual value of $40.1 million for FY2024, which is 5134.38% down from last year.
  • Per National Vision Holdings' latest filing, its Asset Writedowns and Impairment stood at $1.0 million for Q1 2025, which was down 2303.7% from $22.2 million recorded in Q4 2024.
  • In the past 5 years, National Vision Holdings' Asset Writedowns and Impairment registered a high of $80.1 million during Q3 2023, and its lowest value of -$16.5 million during Q1 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $7.2 million, with a median of $999000.0 in 2021.
  • Per our database at Business Quant, National Vision Holdings' Asset Writedowns and Impairment crashed by 9155.44% in 2021 and then surged by 731939.8% in 2024.
  • Quarter analysis of 5 years shows National Vision Holdings' Asset Writedowns and Impairment stood at $519000.0 in 2021, then rose by 12.33% to $583000.0 in 2022, then tumbled by 48.71% to $299000.0 in 2023, then soared by 7319.4% to $22.2 million in 2024, then plummeted by 95.32% to $1.0 million in 2025.
  • Its Asset Writedowns and Impairment was $1.0 million in Q1 2025, compared to $22.2 million in Q4 2024 and $13.7 million in Q3 2024.